129 related articles for article (PubMed ID: 17428659)
1. Synthesis and structure-activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 1.
Ho GD; Bercovici A; Tulshian D; Greenlee WJ; Fawzi A; Smith Torhan A; Zhang H
Bioorg Med Chem Lett; 2007 Jun; 17(11):3023-7. PubMed ID: 17428659
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 2.
Ho GD; Bercovici A; Tulshian D; Greenlee WJ; Fawzi A; Fernandez X; McLeod RL; Smith Torhan A; Zhang H
Bioorg Med Chem Lett; 2007 Jun; 17(11):3028-33. PubMed ID: 17420123
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of N-substituted spiropiperidines as nociceptin receptor ligands: part 2.
Caldwell JP; Matasi JJ; Fernandez X; McLeod RL; Zhang H; Fawzi A; Tulshian DB
Bioorg Med Chem Lett; 2009 Feb; 19(4):1164-7. PubMed ID: 19147350
[TBL] [Abstract][Full Text] [Related]
4. Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors.
Zaveri NT; Journigan VB; Polgar WE
ACS Chem Neurosci; 2015 Apr; 6(4):646-57. PubMed ID: 25635572
[TBL] [Abstract][Full Text] [Related]
5. A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptor.
Zaveri NT; Jiang F; Olsen CM; Deschamps JR; Parrish D; Polgar W; Toll L
J Med Chem; 2004 Jun; 47(12):2973-6. PubMed ID: 15163178
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of 3-substituted N-benzhydryl-nortropane analogs as nociceptin receptor ligands for the treatment of cough.
Yang SW; Ho G; Tulshian D; Greenlee WJ; Fernandez X; McLeod RL; Eckel S; Anthes J
Bioorg Med Chem Lett; 2008 Dec; 18(24):6340-3. PubMed ID: 18990569
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of N-substituted spiropiperidines as nociceptin receptor ligands.
Caldwell JP; Matasi JJ; Zhang H; Fawzi A; Tulshian DB
Bioorg Med Chem Lett; 2007 Apr; 17(8):2281-4. PubMed ID: 17289383
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide.
Trapella C; Fischetti C; Pela' M; Lazzari I; Guerrini R; Calo' G; Rizzi A; Camarda V; Lambert DG; McDonald J; Regoli D; Salvadori S
Bioorg Med Chem; 2009 Jul; 17(14):5080-95. PubMed ID: 19527931
[TBL] [Abstract][Full Text] [Related]
9. 3-(4-Piperidinyl)indoles and 3-(4-piperidinyl)pyrrolo-[2,3-b]pyridines as ligands for the ORL-1 receptor.
Bignan GC; Battista K; Connolly PJ; Orsini MJ; Liu J; Middleton SA; Reitz AB
Bioorg Med Chem Lett; 2006 Jul; 16(13):3524-8. PubMed ID: 16632355
[TBL] [Abstract][Full Text] [Related]
10. Novel non-peptide nociceptin/orphanin FQ receptor agonist, 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: design, synthesis, and structure-activity relationship of oral receptor occupancy in the brain for orally potent antianxiety drug.
Hayashi S; Hirao A; Imai A; Nakamura H; Murata Y; Ohashi K; Nakata E
J Med Chem; 2009 Feb; 52(3):610-25. PubMed ID: 19125610
[TBL] [Abstract][Full Text] [Related]
11. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
[TBL] [Abstract][Full Text] [Related]
12. Structural determinants of opioid and NOP receptor activity in derivatives of buprenorphine.
Cami-Kobeci G; Polgar WE; Khroyan TV; Toll L; Husbands SM
J Med Chem; 2011 Oct; 54(19):6531-7. PubMed ID: 21866885
[TBL] [Abstract][Full Text] [Related]
13. In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations.
Ferrari F; Cerlesi MC; Malfacini D; Asth L; Gavioli EC; Journigan BV; Kamakolanu UG; Meyer ME; Yasuda D; Polgar WE; Rizzi A; Guerrini R; Ruzza C; Zaveri NT; Calo G
Eur J Pharmacol; 2016 Dec; 793():1-13. PubMed ID: 27780725
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel spiropiperidine opioid receptor-like 1 antagonist class by a focused library approach featuring 3D-pharmacophore similarity.
Goto Y; Arai-Otsuki S; Tachibana Y; Ichikawa D; Ozaki S; Takahashi H; Iwasawa Y; Okamoto O; Okuda S; Ohta H; Sagara T
J Med Chem; 2006 Feb; 49(3):847-9. PubMed ID: 16451050
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of the non-peptide nociceptin receptor agonist, Ro64-6198 in Chinese hamster ovary cells expressing recombinant human nociceptin receptors.
Hashiba E; Lambert DG; Jenck F; Wichmann J; Smith G
Life Sci; 2002 Mar; 70(15):1719-25. PubMed ID: 12002517
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists.
Palin R; Barn DR; Clark JK; Cottney JE; Cowley PM; Crockatt M; Evans L; Feilden H; Goodwin RR; Griekspoor F; Grove SJ; Houghton AK; Jones PS; Morphy RJ; Smith AR; Sundaram H; Vrolijk D; Weston MA; Wishart G; Wren P
Bioorg Med Chem Lett; 2005 Feb; 15(3):589-93. PubMed ID: 15664818
[TBL] [Abstract][Full Text] [Related]
17. Discovery of small-molecule nonpeptide antagonists of nociceptin/orphanin FQ receptor: The studies of design, synthesis, and structure-activity relationships for (4-arylpiperidine substituted-methyl)-[bicyclic (hetero)cycloalkanobenzene] derivatives.
Hayashi S; Ohashi K; Mihara S; Nakata E; Emoto C; Ohta A
Eur J Med Chem; 2016 May; 114():345-64. PubMed ID: 27043173
[TBL] [Abstract][Full Text] [Related]
18. Selective and high affinity labeling of neuronal and recombinant nociceptin receptors with the hexapeptide radioprobe [(3)H]Ac-RYYRIK-ol.
Bojnik E; Farkas J; Magyar A; Tömböly C; Güçlü U; Gündüz O; Borsodi A; Corbani M; Benyhe S
Neurochem Int; 2009 Dec; 55(7):458-66. PubMed ID: 19414055
[TBL] [Abstract][Full Text] [Related]
19. Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II.
Journigan VB; Polgar WE; Khroyan TV; Zaveri NT
Bioorg Med Chem; 2014 Apr; 22(8):2508-16. PubMed ID: 24657054
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: integrated drug-design and structure-activity relationships for orally potent, metabolically stable and potential-risk reduced novel non-peptide nociceptin/orphanin FQ receptor agonist as antianxiety drug.
Hayashi S; Hirao A; Nakamura H; Yamamura K; Mizuno K; Yamashita H
Chem Biol Drug Des; 2009 Oct; 74(4):369-81. PubMed ID: 19691471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
